Showing results (11-20 of 24) with videos related to
Sort By:
Pageof 3
Open Forum Infectious Diseases|February 11, 2022
Monitoring Circulating Immune Checkpoint Proteins as Predictors of Non-AIDS Morbid Events in People With HIV Initiating Antiretroviral TherapyThomas A Premeaux, Carlee B Moser, Ashley McKhann, et al.Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|January 3, 2018
Dolutegravir Plus Lamivudine Maintains Human Immunodeficiency Virus-1 Suppression Through Week 48 in a Pilot Randomized TrialBabafemi O Taiwo, Vincent C Marconi, Baiba Berzins, et al.Medrxiv : the Preprint Server for Health Sciences|March 30, 2023
Statistical Challenges when Analyzing SARS-CoV-2 RNA Measurements Below the Assay Limit of Quantification in COVID-19 Clinical TrialsCarlee B Moser, Kara W Chew, Mark J Giganti, et al.The Journal of Infectious Diseases|August 31, 2023
Long COVID After Bamlanivimab TreatmentTeresa H Evering, Carlee B Moser, Nikolaus Jilg, et al.Journal of Clinical and Translational Science|December 2, 2024
Erratum: The statistical design and analysis of pandemic platform trials: Implications for the future - CORRIGENDUMChristopher J Lindsell, Matthew Shotwell, Kevin J Anstrom, et al.Journal of Clinical and Translational Science|November 14, 2024
The statistical design and analysis of pandemic platform trials: Implications for the futureChristopher J Lindsell, Matthew Shotwell, Kevin J Anstrom, et al.The Journal of Infectious Diseases|August 31, 2023
Statistical Challenges When Analyzing SARS-CoV-2 RNA Measurements Below the Assay Limit of Quantification in COVID-19 Clinical TrialsCarlee B Moser, Kara W Chew, Mark J Giganti, et al.Pathogens & Immunity|May 15, 2024
Safety, Efficacy, and Pharmacokinetics of Combination SARS-CoV-2 Neutralizing Monoclonal Antibodies BMS-986414 (C135-LS) and BMS-986413 (C144-LS) Administered Subcutaneously in Non-Hospitalized Persons with COVID-19 in a Phase 2 TrialKatya C Corado, Kara W Chew, Mark J Giganti, et al.Journal of Acquired Immune Deficiency Syndromes (1999)|October 21, 2024
Mortality and Associated Risk Factors Among People Living With HIV With Kaposi Sarcoma: A5263/AMC066 and A5264/AMC067Maganizo B Chagomerana, Carlee B Moser, Minhee Kang, et al.European Journal of Heart Failure|April 19, 2013
Risk assessment for incident heart failure in individuals with atrial fibrillationRenate B Schnabel, Michiel Rienstra, Lisa M Sullivan, et al.Pageof 3